Phocas Financial Corp. Bridge Bio Pharma, Inc. Transaction History

Phocas Financial Corp.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 25, 2022	SELL	$7.34 - $17.16 $405,887 - $948,913	-55,298 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$11.38 - $53.41 $14,725 - $69,112	-1,294 Reduced 2.29%	55,298 $922,000
Q3 2021 Nov 16, 2021	BUY	$46.87 - $64.24 $27,372 - $37,516	584 Added 1.04%	56,592 $2.65 Million
Q2 2021 Aug 16, 2021	BUY	$46.47 - $63.93 $2.6 Million - $3.58 Million	56,008 New	56,008 $3.41 Million

284

170M

7.41M

2.61M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.76B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Phocas Financial Corp., based on Form 13F filings with the SEC.

Stay updated on Phocas Financial Corp. with notifications on news.